Dr Reddy Launches Anti-Cancer Injection in US

Dr. Reddy\’s Laboratories Ltd, a pharmaceutical company based in Hyderabad, Telangana, India recently launched DOCETAXEL Injection USP 20 mg/ml and 80 mg/ 4ml a generic version of TAXOTERE in the US market. The market value of the drug is worth $218 billion in the US Market.

Taxotere (docetaxel) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Dr Reddy\’s Docetaxel injection USP 20 mg/mL and 80 mg/4 mL are available as a single dose, one vial formulation that does not require a prior dilution with a diluent and is ready to add to the intravenous infusion solution.